Research output per year
Research output per year
Fingerprint
Dive into the research topics where Steffen Goletz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Journal article
-
Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trial
Griesinger, G., Dietrich, B., Stöckl, L., Eckert, K., Goletz, S. & Tandler-Schneider, A., 2020, In: Reproductive BioMedicine Online. 40, 2, p. 331-341 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile93 Downloads (Pure) -
A novel scale-down mimic of perfusion cell culture using sedimentation in an automated microbioreactor (SAM)
Kreye, S., Stahn, R., Nawrath, K., Goralczyk, V., Zoro, B. & Goletz, S., 2019, In: Biotechnology Progress. 35, 5, 11 p., e2832.Research output: Contribution to journal › Journal article › Research › peer-review
-
Nanobody-based multispecific multidomain antibody constructs for infectious diseases
Braghetto, M., Goletz, S. & Blixt, K. O.
01/10/2021 → 30/09/2024
Project: PhD
-
Reducing antibody development time with mammalian cell line engineering and bioprocess optimization
Salse Guiu, L., Goletz, S. & Pedersen, L. E.
01/09/2021 → 31/08/2024
Project: PhD
-
Glycoengineering Cytokines and Immunocytokines
Intzilaki, S. E., Goletz, S. & Hafkenscheid, L.
01/05/2021 → 30/04/2024
Project: PhD
-
Glycoengineering immune checkpoint inhibitors
Blomberg, A. L., Goletz, S. & Skovbakke, S. L.
01/04/2021 → 31/03/2024
Project: PhD
-
Novel Strategies and Technologies for the Development of Tumor specific Anitbodies
Gatos, S., Goletz, S. & Blixt, K. O.
01/03/2021 → 30/09/2022
Project: PhD